Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Letrozole and Lapatinib in HER2+/HR+ Breast Cancer
NCT00499681Phase 2Terminated
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Jul 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by Vanderbilt-Ingram Cancer Center. Started Jul 2007; status: terminated.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00499681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499681.